Harrow Share Price

Harrow Share Price

NASDAQ: HROW | Small Cap | Healthcare
$30.43
-$1.64 (-5.13%) Last updated on 21 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Harrow Stock Performance

Open
$31.63
Prev. Close
$32.08
Circuit Range
N/A
Day Range
$30.34 - $32.40
Year Range
$25.84 - $54.77
Volume
32,391
Average Traded
$31.06

Harrow Share Price Today

As of 22 November 2026, Harrow, Inc.'s share price is $30.43. The stock opened at $31.63, compared to its previous close of $32.08. During today's trading session, Harrow, Inc.'s share price traded between $30.34 and $32.40, with an average price of $31.37. Over the past 52 weeks, the stock has recorded a high of $54.77 and a low of $25.84. In terms of performance, Harrow, Inc.'s share price has declined by 13.55% over the last six months and is down 27.03% on a year-on-year basis.

Harrow Share Price Chart

Line chart of the Harrow price trend over the selected period. The price fell overall, ranging from 30.34 to 32.40, ending at 30.43.
$30.34$32.40
L
Show Current Price
H

Harrow Stock Fundamentals & Key Indicators

Market Cap
$1.12B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.76
Revenue (TTM)
$272.30B
Return On Equity (TTM)
-97.60%
Profit Margin
-1.89%
Debt to Equity
10.03
Quarterly Earnings Growth YoY
47.21%

Harrow Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$89.09$44.20$70.66$99.30
Net Profit$6.63-$27.60-$17.27$9.76
Net Profit Margin7.44%-62.44%-24.44%9.83%
Income ChangeN/A-516.29%37.43%156.51%

Harrow Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$88.60$130.19$199.61$272.30
Net Profit-$14.09-$24.41-$17.48-$5.14
Net Profit Margin-15.90%-18.75%-8.76%-1.89%
Income ChangeN/A-73.24%28.39%70.59%

Harrow Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets187.73199.32172.6839.12
Current Assets211.75189.65139.48118.26
Total Assets399.48388.97312.16157.38
Non Current Liabilities251.09228.33192.41111.51
Current Liabilities96.391.3449.3418.63
Total Liabilities347.39319.67241.75130.14
Shareholders' Equity52.0969.370.4127.24

Harrow Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating43.86-22.23.841.71
Investing-5.46-33.16-152.55-1.74
Financing-12.7228.53126.5354.14

About Harrow

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.

Harrow Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$28.30
$30.40
+7.90%
Oct 2026
$30.76
$28.18
-8.58%
Sep 2026
$36.95
$30.82
-19.97%
Aug 2026
$38.40
$38.51
-0.44%
Jul 2026
$43.17
$38.68
-8.95%
Jun 2026
$34.95
$42.48
+20.66%
May 2026
$40.58
$35.20
-13.22%
Apr 2026
$36.16
$40.57
+14.93%
Mar 2026
$53.44
$35.30
-34.94%
Feb 2026
$44.36
$54.26
+32.82%
Jan 2026
$48.91
$40.85
-16.62%
Dec 2025
$40.28
$48.99
+17.45%

Harrow Share Price FAQs